Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer

NCT01575782 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Chloroquine

Sponsor

Maastricht Radiation Oncology